ct

Patent Pick: HA Double-crosser Binds Water, Actives to Skin

May 25, 2016 | Contact Author | By: Rachel Grabenhofer, Cosmetics & Toiletries
Close
Fill out my online form.
  • Article
  • Keywords/Abstract
Holding-water-circle-850

Keywords: hyaluronic acid (HA) | therapeutic | LuroMed | gel | molecular cage | swollen | matrix | film

Abstract: The inventors on this patent literally lay it on thick with cross-linked HA that binds high levels of water and forms a film to deliver water and actives to the skin.

According to this patent, a new gel matrix based cross-linked HA can bind unusually high capacities of water; higher than other natural and synthetic polymers. It also can "cage" and deliver actives to skin in a prolonged manner.

Cross-linked hyaluronic acid for topical cosmetic and therapeutic applications 
U.S. Patent 9345778 
Publication date: May 24, 2016
AssigneeLuroMed LLC 

This patent discloses compositions based on cross-linked hyaluronic acid gels, especially vinyl sulfone cross-linked hyaluronic acid (known as hylan B gel), for topical cosmetic and dermatological formulas.

Excerpt Only This is a shortened version or summary of the article you requested. To view the complete article, please log in or create an account. Registration is Free!

According to this patent, a new gel matrix based cross-linked HA can bind unusually high capacities of water; higher than other natural and synthetic polymers. It also can "cage" and deliver actives to skin in a prolonged manner.

Cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
U.S. Patent 9345778
Publication date: May 24, 2016
Assignee: LuroMed LLC

This patent discloses compositions based on cross-linked hyaluronic acid gels, especially vinyl sulfone cross-linked hyaluronic acid (known as hylan B gel), for topical cosmetic and dermatological formulas.

According to the inventors, the hylan B gel provides prolonged delivery of incorporated substances to the skin surface by imparting a hydrated, substantive and skin-compatible film. The gel acts as a hydrated molecular "cage" (described in U.S. Pat. No. 4,636,524) into which substances may be incorporated. Typically, the composition contains an active ingredient at 10-20% w/w of the total composition.

The gel may be in equilibrium or non-equilibrium form. In non-equilibrium form, the gel is not fully swollen; in equilibrium form, it is and it cannot swell further. The gel matrix has an unusually high capacity to bind water, to a greater degree than other natural and synthetic polymers.

Patent accessed May 24, 2016.